Coronary artery disease Posts on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

Comparing the effectiveness and safety of percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main coronary artery disease.

Comparing the effectiveness and safety of percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main coronary artery disease.

Posted by on Sep 17, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effectiveness and safety of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) in patients with left main (LM) coronary artery disease (CAD). The data showed that both treatments were associated with a similar risk of heart attack, stroke, and death....

Read More

Evaluating the effect of trimetazidine for the treatment of patients with ischemic heart disease who are not suitable for revascularization.

Evaluating the effect of trimetazidine for the treatment of patients with ischemic heart disease who are not suitable for revascularization.

Posted by on May 31, 2022 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effectiveness of trimetazidine (Vastarel) versus other anti-anginal drugs for the treatment of patients with ischemic heart disease (IHD) who are not suitable for revascularization. The data showed that trimetazidine improved walking time and angina attacks in these patients. Some background Coronary artery...

Read More

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Posted by on May 8, 2022 in Coronary artery disease | 0 comments

In a nutshell This study investigated if de-escalation (reducing the intensity) of dual antiplatelet therapy (DAPT) with clopidogrel (Plavix) might be better than ticagrelor (Brilique)-based antiplatelet therapy in stabilized patients with acute myocardial infarction (MI; heart attack) undergoing percutaneous coronary intervention (PCI). The data...

Read More

Is yoga-based cardiac rehabilitation beneficial for patients with coronary artery disease?

Is yoga-based cardiac rehabilitation beneficial for patients with coronary artery disease?

Posted by on Jan 30, 2022 in Coronary artery disease | 0 comments

In a nutshell This study evaluated if yoga-based cardiac rehabilitation leads to reduced heart-related risk factors in patients with coronary artery disease (CAD) compared to standard care. The data showed that the addition of yoga to standard care showed overall improvements in the cardiac health and quality of life of these patients. Some...

Read More

Comparing amphilimus and zotarolimus-eluting stents in patients with diabetes and coronary heart disease.

Comparing amphilimus and zotarolimus-eluting stents in patients with diabetes and coronary heart disease.

Posted by on Dec 31, 2021 in Coronary artery disease | 0 comments

In a nutshell This study compared Cre8 EVO (amphilimus-eluting) stents to Resolute Onyx (zotarolimus-eluting) stents in patients with diabetes and CAD undergoing percutaneous coronary intervention (PCI). The authors concluded that Cre8 EVO stents were similar or better than Resolute Onyx stents in these patients. Some background...

Read More

Does long-term ticagrelor treatment improve outcomes in patients with previous percutaneous coronary intervention?

Does long-term ticagrelor treatment improve outcomes in patients with previous percutaneous coronary intervention?

Posted by on Sep 19, 2021 in Coronary artery disease | 0 comments

In a nutshell This study looked at long-term treatment with ticagrelor (Brilique) after percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD). It found that compared to patients treated with placebo, those treated with ticagrelor were less likely to have a major cardiovascular event (MACE).  Some...

Read More

Does high-dose statin treatment before percutaneous coronary intervention improve outcomes in patients with coronary artery disease?

Does high-dose statin treatment before percutaneous coronary intervention improve outcomes in patients with coronary artery disease?

Posted by on Sep 12, 2021 in Coronary artery disease | 0 comments

In a nutshell This study looked at the use of high-dose statin treatment before percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD). It found that patients who received high-dose statin treatment before PCI were less likely to have a major cardiovascular event (MACE) defined as a heart attack or stroke in the next...

Read More

Will changing to a Mediterranean diet improve cholesterol in patients with coronary heart disease?

Will changing to a Mediterranean diet improve cholesterol in patients with coronary heart disease?

Posted by on Sep 5, 2021 in Coronary artery disease | 0 comments

In a nutshell This study compared the Mediterranean diet (MD) with the low-fat diet (LFD) in patients with coronary artery disease (CAD). It found that after 3 months the MD was associated with higher omega-3 levels than the LFD. Some background Cholesterol is the name commonly used for the fats in the blood. Cholesterol can block the...

Read More

Using beta blockers after a heart attack and long-term patient outcomes

Using beta blockers after a heart attack and long-term patient outcomes

Posted by on Aug 8, 2021 in Coronary artery disease | 0 comments

In a nutshell This study looked at how beta-blockers affected patients following a heart attack. It found that patients using a low dose of beta-blockers had better outcomes one year later. Some background Following a heart attack, there are several treatment options available to improve outcomes. One treatment is beta-blockers (BBs), which prevent...

Read More

Should antiplatelet treatment after PCI be tailored to individual patients?

Should antiplatelet treatment after PCI be tailored to individual patients?

Posted by on Aug 8, 2021 in Coronary artery disease | 0 comments

In a nutshell This study evaluated whether antiplatelet therapy after percutaneous coronary intervention (PCI) should be given personalized for each patient. It found that guided therapy resulted in a reduction in the overall risk of heart attack, stroke, and death compared to standard therapy. Some background Percutaneous coronary...

Read More